Precirix SA
Dissolution volontaire – liquidation 20.6 FTEThe score of Precirix shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -86 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Precirix's annual accounts
Filed annual accounts
- Year ended 17 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 23 May 2024
- Year ended 31 Dec 2022filed on 25 May 2023
- Year ended 31 Dec 2021filed on 25 May 2022
Precirix's financial analysis
- Solvency-406.7%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Precirix
Precirix's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0564.736.473
- VAT number
- BE0564736473
- Peppol
- Registered · 0208:0564736473 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Oct 2014
- Registered office
- 1090 Jette
- Size
- Small · 20.6 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Precirix (SA) has been based in Jette since 2014, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €15.7m and equity of −€15.7m; its revenue is not published. With 20.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -406.7%, below the median of its sector (48.8%).
Companies similar to Precirix
Companies in the same business, of comparable size and area, outside its group.
- Santero Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.15m
- Cancer State Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.96m
- Zymofix Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.41m
- BiometrIQ Research and experimental development on natural sciences and engineering Kortrijk · balance sheet €1.65m
- Nexelis Europe Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.65m
- Protealis Research and experimental development on natural sciences and engineering Ghent · balance sheet €11.1m
- Biotalys Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.3m
- Dendrogenix Research and experimental development on natural sciences and engineering Liège · balance sheet €5.28m
Frequently asked questions about Precirix
What is the revenue of Precirix?
Precirix files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Precirix?
In Belgium, the VAT number is the company number prefixed with BE: BE0564736473 for Precirix, if the company is VAT-registered. Its company number (CBE) is 0564.736.473.
Where is the registered office of Precirix?
According to the CBE register, the registered office of Precirix is in 1090 Jette.
What is the equity of Precirix?
At the close of the 2025 financial year, the equity of Precirix amounts to -15,664,388 €, a solvency of -406.7% of total assets.
How many people work at Precirix?
20.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Precirix?
The register lists 2 active mandates at Precirix. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Precirix
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →